Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Drug and Medication Analysis & Statistics, March 2014 (p5)

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

121-170 of about 5 000 reports
Ovarian Cancer Drug Pathway Analyzer 2014

Ovarian Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 320 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014

Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 262 conjugated drugs known to affect more than 206 specific intracellular signaling pathways for the treatment ...

  • Industries : Drug and Medication
Pancreatic Cancer Drug Pathway Analyzer 2014

Pancreatic Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 294 targeted molecular therapies known to affect more than 246 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pipeline Update 2014

Colorectal Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...

  • Industries : Drug and Medication
Targeting Natural Killer Cell Mediated Cytotoxicity in Cancer Drug Pipeline Update 2014

Targeting Natural Killer Cell Mediated Cytotoxicity in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, ...

  • Industries : Drug and Medication
Orphan Drugs in Oncology Drug Pipeline Update 2014

Orphan Drugs in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

This is a worldwide report on cancer drugs which have now or in the past received orphan drug status. This product will give you unique access not only to those cancer indications in which drugs are being ...

  • Industries : Drug and Medication
Renal Cancer Drug Pipeline Update 2014

Renal Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The high existing unmet need in the treatment of renal cancer is reflected by the poor prognosis of patients with advanced stage disease, five- year survival rates with existing cytokine therapy being ...

  • Industries : Drug and Medication
Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2014

Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 177 companies plus partners developing 303 targeting actin cytoskeleton modulators drugs in 1149 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated ...

  • Industries : Drug and Medication
Brain Cancer Drug Pathway Analyzer 2014

Brain Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 213 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Conjugated Drugs in Oncology Drug Pipeline Update 2014

Conjugated Drugs in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Among conjugated drugs in oncology, antibody-drug conjugates (ADCs) are by far getting the most attention as a new drug class. Owing to improved technology and appropriate targeting, the clinical application ...

  • Industries : Drug and Medication
Head and Neck Cancer Drug Pipeline Update 2014

Head and Neck Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 141 companies plus partners developing 153 drugs targeting head and neck cancer in development. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs ove ...

  • Industries : Drug and Medication
Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014

Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified ...

  • Industries : Drug and Medication
Mitochondrial Drugs in Oncology Drug Pipeline Update 2014

Mitochondrial Drugs in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Focusing on mitochondria has recently become an intriguing target for cancer therapy. It is well known that mitochondrial activity in tumor cells is suppressed and exploiting the differences in mitochondrial ...

  • Industries : Drug and Medication
Snap shot report of I/E analysis of Carbendazim

Snap shot report of I/E analysis of Carbendazim

  • $ 1 788
  • Industry report
  • April 2014
  • by CCM International Limited

To help clients have an overall understanding of import/export situation of Carbendazim. It is the analysis summary of Carbendazim's Import/Export analysis. It is published monthly and it would include ...

  • Industries : Drug and Medication
Midazolam: Pipeline™ Developer: Patent Report

Midazolam: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Topiramate: Pipeline™ Developer: Patent Report

Topiramate: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Risperidone: Pipeline™ Developer: Patent Report

Risperidone: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Glimepiride: Pipeline™ Developer: Patent Report

Glimepiride: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Montelukast: Pipeline™ Developer: Patent Report

Montelukast: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Terbinafine: Pipeline™ Developer: Patent Report

Terbinafine: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Pramipexole: Pipeline™ Developer: Patent Report

Pramipexole: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Temozolomide: Pipeline™ Developer: Patent Report

Temozolomide: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Riluzole: Pipeline™ Developer: Patent Report

Riluzole: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Desloratadine: Pipeline™ Developer: Patent Report

Desloratadine: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Mirtazapine: Pipeline™ Developer: Patent Report

Mirtazapine: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Cladribine: Pipeline™ Developer: Patent Report

Cladribine: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Lamotrigine: Pipeline™ Developer: Patent Report

Lamotrigine: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Cisatracurium Besylate: Pipeline™ Developer: Patent Report

Cisatracurium Besylate: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Meloxicam: Pipeline™ Developer: Patent Report

Meloxicam: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Orlistat: Pipeline™ Developer: Patent Report

Orlistat: Pipeline™ Developer: Patent Report

  • $ 1 681
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication

» Read our Company Profiles

85 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.